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ABSTRACT
The increased oral Candida colonization that resulted for radiotherapy often leads to candidiasis. Intensity
Modulated Radiotherapy (IMRT) is a technique of delivering radiation with improved dose distributions sparing
the surrounding normal tissue and decreasing the ill-effects. Objective: To identify and quantify changes in the
Candidal carriage of patients undergoing IMRT for head and neck malignancy. Methods: Saliva from 37 patients
undergoing IMRT for head and neck malignancy was collected. The Candida species profile pre- and post-IMRT
was evaluated using semi quantitative fungal culture. The changes in the distribution of the growth of Candida
species due to IMRT was analyzed using Wilcoxon sign rank test. Results: Twenty-two patients were Candidapositive pre-IMRT, while 24 patients were Candida-positive post-IMRT. Candida species isolates pre-IMRT were
C. albicans (63%), C. tropicalis (26%), C. glabrata (7%), C. krusei (4%) and post-IMRT, were C. albicans (55%),
C. tropicalis (30%), C. glabrata (12%) and C. krusei (3%). C. albicans showed increased growth post-IMRT in
the range of 103 to 104 colony-forming units per ml of saliva (p>0.05). Conclusion: There was no significant effect
of IMRT on the distribution of growth of Candida. Candida albicans was the most common species. A change
towards non C. albicans species post-IMRT was seen.
Keywords: Candida, head and neck malignancy, IMRT, radiotherapy

Radiation therapy is the most common form of
t reat ment ad ministered to patients with such
malignancies. There are different forms of radiation
therapy, including 3D Conformal Radiation Therapy
(3D CRT), Intensity-Modulated Radiation Therapy
(IMRT), and brachytherapy, which are the commonly
employed modalities of treatment for malignancies of
the head and neck.4

INTRODUCTION
Candida species are a normal constituent of the human
oral micro-flora. They are naturally harmless, but
become pathogenic when the host immune barriers are
violated. Recently, their increase in pathogenic state
has been observed, this could be attributed to various
medical conditions and their interventions. One such
reason is oral cancer and its treatment protocols.1

The effects thus seen in the oral cavity due to
radiotherapy include mucositis, xerostomia, radiation
caries, dysgeusia, candidial infections- all leading to
an altered dietary intake, thus, resulting in malnutrition
which further decreases the general health in an already
diseased human being.5,6 The purpose of this study
was to identify and quantify Candida species in saliva
collected from patients undergoing IMRT for head
and neck malignancy and to see the change that IMRT
brought about to the Candidal carriage in such patients.

Cancer is a multifactorial disease in which a cell
or a group of cells display uncontrolled growth,
invasion, and sometimes metastasis. The term head
and neck malignancy refers to a group of cancers with
similarities in their biological background, originating
from the upper aero digestive tract, including the lip,
oral cavity, nasal cavity, paranasal sinuses, pharynx,
and larynx.2,3
7
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METHODS
In the present study, thirty-seven patients were
included. All these patients were receiving IMRT for
a head and/ or neck malignancy. None of the patients
were taking antibiotics and antifungals during the
study and patients who had a systemic illness that
would make them more prone for candidial infections
were excluded from the study. Ethical clearance for
the study was obtained from the Institutional Ethics
Committee. After informing the patients regarding
the nature of the study and after obtaining written
consent, saliva was collected from all the patients
for Candida culture procedures at baseline, i.e. the
day of the commencement of radiotherapy and on
the last day of their treatment protocol immediately
after radiotherapy, by asking them to spit into a sterile
container provided. The patients received a total dose
of 50.4-70 gray. This dose was divided into fractions
ranging from 28-39 fractions.

Figure 1. Distribution of subjects according to age and
gender

Semi-quantitative culture was done for the saliva
specimen.7 About 10µl of saliva was streaked onto
the culture plate using a four-millimetre nichrome
loop on commercial media, Sabouraud’s dextrose
agar (HiMedia Laboratories, Mumbai, India) and then
on Candida CHROM agar (HiMedia Laboratories,
Mumbai, India), for culture of fungi. The culture
media was incubated at 370C for 24-48 hours. After
the incubation time, the fungi grown on the media
was identified by Gram’s staining, Germ tube test and
colony colour on CHROM agar as per manufacturer’s
chart. Light green colonies were identified as C.
albicans, blue colonies were identified as C. tropicalis,
cream to white colonies were identified as C. glabrata
and purple colonies were identified as C. krusei. The
different colonies grown in 10µl of saliva were counted
and converted further for 1000µl (One ml.) of saliva.
The semi-quantitative colony count was categorized
as <103, 103 to 104, 104 to 105, 105 to106 and >106 colony
forming units per ml (cfu/ml) of saliva.

Figure 2. Type malignancies of patients receiving IMRT

Post-IMRT, out of 24 patients that had a positive
isolation of Candida, 55% had isolates of C. albicans,
30% had isolates of C. tropicalis, 12% had isolates of
C. glabrata and 3% had isolates of C. krusei (Figure
4 and 5).

RESULTS

Out of the 20 patients who showed no growth of C.
albicans pre-IMRT, seven patients showed increased
C. albicans growth post-IMRT out of which, 5 (25%)
patients showed growth in the range of 103-104 cfu/ml
and 2 (10%) patients showed growth in the range of
105-106 cfu/ml.

The study consisted of 37 subjects who were undergoing
IMRT for head and/ or neck malignancy. The mean age
of the 37 patients was 50.54 years, 62.2% were male
and 37.8% females (Figure 1). Most of the malignancies
were those of the buccal mucosa, which affected
18.9% of the subjects; followed by carcinoma of the
oropharynx, which was diagnosed in 16.2% of the
subjects (Figure 2).

Similarly, out of the 30 patients who showed no growth
of C. tropicalis pre-IMRT, nine patients showed
increased growth post-IMRT out of which, 1 (3.3%)
showed <103 cfu/ml and 8 (26.7%) showed increased
growth in the range of 103-104 cfu/ml and out of 35
patients that showed no growth of C. glabrata preIMRT, 5 (14.3%) patients showed increased growth
in the range of 103-105 cfu/ml and out of 36 patients

Out of the 37 patients, 22 (54.05%) patients had isolates
of Candida pre-IMRT and 24 (67.56%) patients had
isolation of Candida post-IMRT. Out of 22 patients who
had positive Candida isolates pre-IMRT, 63% had C.
albicans, 26% had C. tropicalis, 7% had C. glabrata,
and 4% had C. krusei (Figure 3).
8
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Figure 5. Candida species isolated from saliva after IMRT
Figure 3. Candida species identification on Candida
CHROM agar (HiMedia Laboratories, Mumbai,
India)

only when there is a disruption in the balance of the
internal environment.9,10
Patients who have been irradiated to the head and neck
region end up having xerostomia that ranges from mild
decrease of saliva and inability to eat solid dry food
to complete absence of saliva. The host capacity is
decreased resulting in reduced clearance of Candida
organisms, thus causing it to flourish. Antimicrobial
properties of saliva, that normally keep the oral micro
flora in check are also absent or diminished. Altered
pH and buffering capacity of saliva also plays a role
in candidiasis.11,12
IMRT is a new and advanced technique of delivering
radiation in a precise manner. This high-precision
radiation therapy uses computer-controlled linear
accelerator (linac) that delivers the dose to the tumor or
specific areas that lie within the tumor. IMRT, makes
it possible to generate dramatically improved dose
distributions, that are tailored to fit complex shapes of
the tumour and delivers optimum dose of radiation to
the malignancy, sparing the surrounding normal tissue
thus decreasing the ill effects of radiation that was seen
with conventional radiotherapy.13-15

Figure 4. Candida species isolated from saliva before IMRT

that showed no growth of C. krusei pre-IMRT, only 1
(2.8%) showed increased growth in the range of 103-104
cfu/ml (Table 1).
Wilcoxon Sign rank test was done to assess the
distribution of the growth of Candida species due
to IMRT (Table 2). Only C. albicans showed an
increased pattern of growth due to IMRT. Majority of
the patients who showed no growth of C. albicans preIMRT, showed increased growth post-IMRT and this
growth was in the range of 103 to 104. But this change
in the distribution of growth of C. albicans was not
statistically significant (p>0.05).

The amount of radiation delivered for a malignancy of
the head and neck region usually ranges from 50-70
gray. Similar range of dose was also delivered to the
patients in this study. Any dose above 52 gray can
result in dysfunction of the salivary gland, resulting
in xerostomia, which is seldom reversible and causes
decreased clearance of oral Candida organisms,
increasing its colonization making it pathogenic.16,17

DISCUSSION

There are various species of Candida that can be
isolated from the oral cavity; the most prominent
ones are C. albicans, followed by C. tropicalis and C.
glabrata. Previous study identified that C. albicans
was isolated from more than half (59%) of the patients
undergoing radiotherapy.18,19 This was also seen in our
study where post-IMRT 55% of the Candida isolates
were C.albicans. But the distribution of C. albicans
post-IMRT was not statistically significant.

The Latin root word “candid” perfectly describes
Candida, which means white. They are yeasts that
are described under the fungus kingdom. Candida
is a dimorphic fungus that can be found in yeast and
hyphae forms, a property, which makes it retain its
harmless commensal state or become invasive and turn
pathogenic.8 Seen as a normal commensal in most of the
mucosal surfaces, it becomes invasive and pathogenic
9
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Table 1. The colony forming units of different candida species pre-IMRT and post-IMRT in one ml of saliva (CFU/ml)
Pre-IMRT
Candida Species

Post-IMRT

No growth
N(%)

No growth

1(50)

1(8.3)

0

15(40.5)

0

2(16.7)

1(33.3)

3(8.1)

103-104

5(25)

1(50)

7(58.3)

1(33.3)

14(37.8)

4

5

10 -10

0

0

2(16.7)

1(33.3)

3(8.1)

10 -10

6

2(10)

0

0

0

2(5.4)

No growth

21(70)

1(100)

3(60.0)

0

25(67.6)

<10

1(3.3)

0

2(40.0)

0

3(8.1)

10 -10

8(26.7)

0

0

1(100.0)

9(24.3)

No growth

30(85.7)

0

2(100.0)

0

32(86.5)

103-104

3(8.6)

0

0

0

3(8.1)

10 -10

2(5.7)

0

0

0

2(5.4)

35(97.2)

0

1(100.0)

0

36(97.3)

1(2.8)

0

0

0

1(2.7)

3

3

C. glabrata

4

C. krusei

Total

104-105
N(%)

0

5

C. tropicalis

103-104
N(%)

13(65)

<103
C albicans

<10
N(%)
3

4

5

No growth
10 -10
3

4

Table 2. Distribution of the growth of Candida species pre- and post-IMRT
IMRT
Candida species
Pre
C. albicans

Post
Pre

C. tropicalis

Post
Pre

C. glabrata

Post
Pre

C. krusei

Post

N

Range

Median (Q1-Q3)

37

No growth - 10 to
105

No growth (No growth –
104 to 105)

37

No growth - 105 to
106

103to104 (No growth – 103
to 104)

37

No growth - 104to105

No growth (No growth –
No growth)

37

No growth – 103 to
104

No growth (No growth –
103 to 104)

37

No growth – 103 to
104

No growth (No growth –
No growth)

37

No growth - 10 to10

No growth (No growth –
No growth)

37

No growth – 103 to
104

No growth (No growth –
No growth)

37

No growth – 103 to
104

No growth (No growth –
No growth)

4

4

5

Wilcoxon Sign rank
test
z

p-value

-1.58

0.11(NS)

-1.24

0.22(NS)

-1.41

0.16(NS)

0.00

1.00(NS)

p>0.05 Non significant, NS

Other study also put forth similar findings, where
after C. albicans, the species isolated were C.glabrata,
C.krusei, and C.tropicalis. This was also shown by
a study by Dambroso D et al., who established that
radiotherapy is an important influencing factor for oral
candidiasis.20,21 Our study also showed that Candida
was seen to increase post IMRT.

of the patients post radiotherapy. In our study, postIMRT, 45% of the Candida species isolated was NCAC
(C. tropicalis, C. glabrata and C. krusei). Although our
study showed similar species isolation, the percentage
isolated was much less, this could be attributed to the
fact that some of the patients in the study by Jham
BC et al., were undergoing conventional radiotherapy
as compared to our study where the patients were
undergoing IMRT.22

It was showed that oral cavity colonization by nonCandida albicans Candida (NCAC) was seen in 71.4%
10
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In a study on 37 patients receiving radiotherapy
showed that, NCAC was emerging, as the new cause
for Candidiasis and was seen in 30% of the cases, as
was in line with our study and further went to say that
Chromogenic media was most helpful in identifying
these infections quickly and accurately. 23 Similarly
in our study, Candida species was identified using
Candida CHROM agar. This is a chromogenic media,
which can identify more than one organism on a single
medium by observing the distinct colour change in
the medium, which allows for an easier and accurate
differentiation.20

2.

Irradiation-induced xerostomia favors intraoral
colonization of Candida species, especially C. albicans,
as supported by a previous study which also stated that
Candida species had an ability to adapt and increase its
survival in the oral cavity, particularly when salivary
defenses are weakened chiefly due to radiotherapy.24
This was also in agreement with our study where
the oral cavity was colonized mainly by C. albicans,
although, the change in the pattern of growth of C.
albicans was not statistically significant. Moreover,
xerostomia was also seen in all of our patients, and thus
collection of saliva became very difficult post-IMRT.

6.

It identified that C. glabrata strains caused an infection
in patients receiving radiotherapy.25 In our study, out of
the 35 patients that showed no isolates of C. glabrata
pre-IMRT, 14.3% of the patients showed growth
post-IMRT in the range of 103 to 105 cfu/ml of saliva,
although this was not statistically significant, never the
less, infections could arise from C. glabrata.
Increase in Candida isolates post-radiotherapy seen in
a study by Yogitha PVV et al., was attributed to poor
oral hygiene and inadequate nutrition. 26 Although
inadequate nutrition could be a reason due to mucositis
and thus inability to eat, the subjects in our study were
given oral prophylaxis prior to RT and the teeth with
poor prognosis were extracted, hence, the reason of
poor oral hygiene could be safely excluded from our
study as a causative factor.

CONCLUSION
The most common species that was isolated in patients
undergoing Intensity Modulated Radiotherapy for a
head and neck malignancy was C. albicans, followed by
C. tropicalis, C. glabrata and C. krusei. There was also
a change seen towards Non Candida albicans Candida
species post Intensity Modulated Radiotherapy.
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